Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Debra Dyer to Lung Neoplasms

This is a "connection" page, showing publications Debra Dyer has written about Lung Neoplasms.

 
Connection Strength
 
 
 
2.172
 
  1. Dyer DS, White C, Conley Thomson C, Gieske MR, Kanne JP, Chiles C, Parker MS, Menchaca M, Wu CC, Kazerooni EA. A Quick Reference Guide for Incidental Findings on Lung Cancer Screening CT Examinations. J Am Coll Radiol. 2023 02; 20(2):162-172.
    View in: PubMed
    Score: 0.356
  2. Dyer DS, Zelarney PT, Carr LL, Kern EO. Improvement in Follow-up Imaging With a Patient Tracking System and Computerized Registry for Lung Nodule Management. J Am Coll Radiol. 2021 07; 18(7):937-946.
    View in: PubMed
    Score: 0.314
  3. Byrne SC, Jacobson FL, Hammer MM, Dyer DS. Deferral and Resumption of Lung Cancer Screening After COVID-19 Surge: Patient Perspectives From Two Institutions. J Am Coll Radiol. 2021 04; 18(4):601-604.
    View in: PubMed
    Score: 0.307
  4. Berland LL, Monticciolo DL, Flores EJ, Malak SF, Yee J, Dyer DS. Relationships Between Health Care Disparities and Coverage Policies for Breast, Colon, and Lung Cancer Screening. J Am Coll Radiol. 2019 Apr; 16(4 Pt B):580-585.
    View in: PubMed
    Score: 0.276
  5. Jett JR, Dyer DS. Should lung cancer screening with low-dose computed tomography be routine for smokers and former smokers? should low-dose CT Be routine in these patients? Most certainly! Clin Adv Hematol Oncol. 2014 Oct; 12(10):701-3.
    View in: PubMed
    Score: 0.202
  6. Gould MK, Creekmur B, Qi L, Golden SE, Kaplan CP, Walter E, Mularski RA, Vaszar LT, Fennig K, Steiner J, de Bie E, Musigdilok VV, Altman DA, Dyer DS, Kelly K, Miglioretti DL, Wiener RS, Slatore CG, Smith-Bindman R. Emotional Distress, Anxiety, and General Health Status in Patients With Newly Identified Small Pulmonary Nodules: Results From the Watch the Spot Trial. Chest. 2023 12; 164(6):1560-1571.
    View in: PubMed
    Score: 0.092
  7. Nair A, Dyer DS, Heuvelmans MA, Mashar M, Silva M, Hammer MM. Contextualizing the Role of Volumetric Analysis in Pulmonary Nodule Assessment: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2023 03; 220(3):314-329.
    View in: PubMed
    Score: 0.088
  8. Sahar L, Douangchai Wills VL, Liu KKA, Fedewa SA, Rosenthal L, Kazerooni EA, Dyer DS, Smith RA. Geographic access to lung cancer screening among eligible adults living in rural and urban environments in the United States. Cancer. 2022 Apr 15; 128(8):1584-1594.
    View in: PubMed
    Score: 0.084
  9. Chelala L, Hossain R, Kazerooni EA, Christensen JD, Dyer DS, White CS. Lung-RADS Version 1.1: Challenges and a Look Ahead, From the AJR Special Series on Radiology Reporting and Data Systems. AJR Am J Roentgenol. 2021 06; 216(6):1411-1422.
    View in: PubMed
    Score: 0.078
  10. Gould MK, Altman DE, Creekmur B, Qi L, de Bie E, Golden S, Kaplan CP, Kelly K, Miglioretti DL, Mularski RA, Musigdilok VV, Smith-Bindman R, Steltz JP, Wiener RS, Aberle DR, Dyer DS, Vachani A. Guidelines for the Evaluation of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Awareness, Agreement, and Adherence From the Watch the Spot Trial. J Am Coll Radiol. 2021 Apr; 18(4):545-553.
    View in: PubMed
    Score: 0.077
  11. Sahar L, Douangchai Wills VL, Liu KK, Kazerooni EA, Dyer DS, Smith RA. Using Geospatial Analysis to Evaluate Access to Lung Cancer Screening in the United States. Chest. 2021 02; 159(2):833-844.
    View in: PubMed
    Score: 0.076
  12. Gould MK, Smith-Bindman R, Kelly K, Altman DE, Barjaktarevic I, Creekmur B, de Bie E, Dyer DS, Mortani Barbosa EJ, Mularski RA, Qi L, Vaszar LT, Yu S, Miglioretti DL. Methods for the Watch the Spot Trial. A Pragmatic Trial of More- versus Less-Intensive Strategies for Active Surveillance of Small Pulmonary Nodules. Ann Am Thorac Soc. 2019 12; 16(12):1567-1576.
    View in: PubMed
    Score: 0.072
  13. Kazerooni EA, Austin JH, Black WC, Dyer DS, Hazelton TR, Leung AN, McNitt-Gray MF, Munden RF, Pipavath S. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J Thorac Imaging. 2014 Sep; 29(5):310-6.
    View in: PubMed
    Score: 0.050
  14. Mohammed TL, Chowdhry A, Reddy GP, Amorosa JK, Brown K, Dyer DS, Ginsburg ME, Heitkamp DE, Jeudy J, Kirsch J, MacMahon H, Parker JA, Ravenel JG, Saleh AG, Shah RD. ACR Appropriateness Criteria? screening for pulmonary metastases. J Thorac Imaging. 2011 Feb; 26(1):W1-3.
    View in: PubMed
    Score: 0.039
  15. Jeudy J, Khan AR, Mohammed TL, Amorosa JK, Brown K, Dyer DS, Gurney JW, MacMahon H, Saleh AG, Vydareny KH. ACR Appropriateness Criteria hemoptysis. J Thorac Imaging. 2010 Aug; 25(3):W67-9.
    View in: PubMed
    Score: 0.038
  16. Dennie C, Dyer D, Goo JM, Revel MP. The Global Reading Room: A Likely Infectious Abnormality on Lung Cancer Screening CT. AJR Am J Roentgenol. 2022 03; 218(3):556-557.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)